Filing Flows › Tela Bio (TELA) › R&D spending
Tela Bio (TELA) R&D spending by quarter
Tela Bio's R&D spending was $2.7M in Q2 2026 (second quarter 2026), +16% from Q1 2026. Over the last 7 quarters it ranged from $2.0M (Q4 2024) to $2.7M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $2.7M | +16% | +24% |
| Q1 2026 | $2.3M | +10% | -8% |
| Q4 2025 | $2.1M | -9% | +5% |
| Q3 2025 | $2.3M | +7% | — |
| Q2 2025 | $2.2M | -13% | — |
| Q1 2025 | $2.5M | +25% | — |
| Q4 2024 | $2.0M | — | — |
Q2 2026 at a glance
Tela Bio, Q2 2026: revenue $19.3M (-4% year over year), operating margin -48.1%, net loss $11.3M, operating cash flow −$9.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Tela Bio's R&D spending?
Tela Bio's R&D spending was $2.7M in Q2 2026 (second quarter 2026), +16% from Q1 2026.
How has Tela Bio's R&D spending changed?
Over the last 7 quarters it ranged from $2.0M (Q4 2024) to $2.7M (Q2 2026).